Copyright
©The Author(s) 2004.
World J Gastroenterol. Mar 15, 2004; 10(6): 864-870
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.864
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.864
Figure 5 Plasma GSH- and GSSG concentrations following liver transplantation.
Compared to sham-operated animals (n = 5) a significant increase of reduced and oxidized glutathione was determined upon reperfusion of untreated grafts (n = 8). Intravenous infusion of GSH at rates of 50 µmol/(h·kg) (n = 5) and 100 µmol/(h·kg) (n = 5) resulted in a dose- dependent in-crease of plasma GSH concentrations. The corresponding GSSG levels showed only a slight increase after administration of 50 µmol GSH/(h·kg), but increased markedly following infusion of 100 µmol GSH/(h·kg). Mean ± SE. aP < 0.05 vs sham; bP < 0.001 and cP < 0.05 vs control group; eP < 0.05 vs GSH 50 and fP < 0.01 vs GSH 50.
- Citation: Schauer RJ, Kalmuk S, Gerbes AL, Leiderer R, Meissner H, Schildberg FW, Messmer K, Bilzer M. Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation. World J Gastroenterol 2004; 10(6): 864-870
- URL: https://www.wjgnet.com/1007-9327/full/v10/i6/864.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i6.864